The contribution of proton magnetic resonance spectroscopy ( 1 HMRS) to clinical brain tumour diagnosis
暂无分享,去创建一个
A R Tate | J R Griffiths | F A Howe | F. Howe | J. Griffiths | A. R. Tate | B. Bell | A. Clifton | A. Loosemore | S. Cudlip | P. Wilkins | B A Bell | M Murphy | A Loosemore | A G Clifton | S A Cudlip | P R Wilkins | M. Murphy | John R. Griffiths | Simon Cudlip | Andrew Clifton | F. A. Howe
[1] J. Frahm,et al. Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS , 1998, Magnetic resonance in medicine.
[2] J. Frahm,et al. Localized proton NMR spectroscopy of brain tumors using short-echo time STEAM sequences. , 1991, Journal of computer assisted tomography.
[3] J. Ruíz-Cabello,et al. Phospholipid metabolites as indicators of cancer cell function , 1992, NMR in biomedicine.
[4] Vanhamme,et al. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge , 1997, Journal of magnetic resonance.
[5] M. Castillo,et al. Proton MR spectroscopy of common brain tumors. , 1998, Neuroimaging clinics of North America.
[6] W. Negendank,et al. Studies of human tumors by MRS: A review , 1992, NMR in biomedicine.
[7] A. Falini,et al. Proton magnetic resonance spectroscopy and intracranial tumours: Clinical perspectives , 1996, Journal of Neurology.
[8] Rosemary Luckin,et al. A Prototype Decision Support System for MR Spectroscopy-Assisted Diagnosis of Brain Tumours , 2001, MedInfo.
[9] Mark Noble,et al. Characteristic metabolic profiles revealed by 1H NMR spectroscopy for three types of human brain and nervous system tumours , 1995, NMR in biomedicine.
[10] F Lazeyras,et al. Single-voxel proton brain spectroscopy exam (PROBE/SV) in patients with primary brain tumors. , 1996, AJR. American journal of roentgenology.
[11] W. Paulus,et al. Intratumoral histologic heterogeneity of gliomas. A quantitative study , 1989, Cancer.
[12] Quanjun Zhao,et al. Stereotactic Biopsy for Intracranial Space-Occupying Lesions: Clinical Analysis of 550 Cases , 2001, Stereotactic and Functional Neurosurgery.
[13] M. Castillo,et al. Proton MR spectroscopy in neoplastic and non-neoplastic brain disorders. , 1998, Magnetic resonance imaging clinics of North America.
[14] J. Griffiths,et al. Nuclear magnetic resonance spectroscopy of cancer. , 1997, The British journal of radiology.
[15] N. Lundbom,et al. Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. , 1997, Journal of Neurosurgery.
[16] B. Scheithauer,et al. Histological Typing of Tumours of the Central Nervous System , 1993, World Health Organization.
[17] P J Kelly,et al. A histologic and cytologic method for the spatial definition of gliomas. , 1987, Mayo Clinic proceedings.
[18] L. Turnbull,et al. Combined proton MR spectroscopy and dynamic contrast enhanced MR imaging of human intracranial tumours in vivo , 2000, NMR in biomedicine.
[19] B D Ross,et al. Absolute Quantitation of Water and Metabolites in the Human Brain. I. Compartments and Water , 1993 .
[20] P G Webb,et al. Automated single‐voxel proton MRS: Technical development and multisite verification , 1994, Magnetic resonance in medicine.
[21] R L Ehman,et al. Cerebral astrocytomas: histopathologic correlation of MR and CT contrast enhancement with stereotactic biopsy. , 1988, Radiology.
[22] Risto A. Kauppinen,et al. Diagnostic assessment of brain tumours and non-neoplastic brain disorders in vivo using proton nuclear magnetic resonance spectroscopy and artificial neural networks , 1999, Journal of Cancer Research and Clinical Oncology.
[23] O. G. Dodge,et al. Histological Typing of tumours of the Central Nervous System , 1981, British Journal of Cancer.
[24] L D Lunsford,et al. Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma. , 1993, Journal of neurosurgery.
[25] P Bachert,et al. Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy. , 2001, AJNR. American journal of neuroradiology.
[26] A R Tate,et al. Towards a method for automated classification of 1H MRS spectra from brain tumours , 1998, NMR in biomedicine.
[27] H. Poptani,et al. Cystic intracranial mass lesions: possible role of in vivo MR spectroscopy in its differential diagnosis. , 1995, Magnetic resonance imaging.
[28] D. Louis Collins,et al. Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy , 1996, Nature Medicine.
[29] S. Kannuki,et al. Non‐invasive Characterization of Brain Tumor by in‐vivo Proton Magnetic Resonance Spectroscopy , 1995, Japanese journal of cancer research : Gann.
[30] M Ala-Korpela,et al. Automated classification of human brain tumours by neural network analysis using in vivo 1H magnetic resonance spectroscopic metabolite phenotypes. , 1996, Neuroreport.
[31] V. L. Doyle,et al. Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy , 2003, Magnetic resonance in medicine.
[32] O Henriksen,et al. In vivo quantitation of metabolite concentrations in the brain by means of proton MRS , 1995, NMR in biomedicine.
[33] G. Matson,et al. Quantitation of in vivo phosphorus metabolites in human brain with magnetic resonance spectroscopic imaging (MRSI). , 1993, Magnetic resonance imaging.
[34] Margarida Julià-Sapé,et al. Automated Classification of Brain Tumours from 1H MRS Spectra in INTERPRET, a Multi-Centre Collaboration , 2002 .